Global Breakthrough Therapy (BT) Designation Market Growth (Status and Outlook) 2022-2028
- LP 4851591
- 124 Pages
- February 2022
- Medical Devices
The United States Breakthrough Therapy (BT) Designation market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Breakthrough Therapy (BT) Designation market, reaching US$ million by the year 2028. As for the Europe Breakthrough Therapy (BT) Designation landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Breakthrough Therapy (BT) Designation players cover Roche, Abbvie, Novartis International AG, and Janssen, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Breakthrough Therapy (BT) Designation market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Oncology
Infectious Diseases
Rare Diseases
Autoimmune Diseases
Pulmonary Diseases
Neurological Disorders
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Hospital
Clinic
Research Institute
Laboratories
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Roche
Abbvie
Novartis International AG
Janssen
BMS
Eli Lilly
Gilead
Sanofi
Regeneron
Acadia
Boehringer Ingelheim
Amgen
AstraZeneca
GlaxoSmithKline
Vertex
Alexion
Merck
Jazz Pharmaceuticals
Exelixis
Eisai
Takeda
Pfizer
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Breakthrough Therapy (BT) Designation Market Size 2017-2028
2.1.2 Breakthrough Therapy (BT) Designation Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Breakthrough Therapy (BT) Designation Segment by Type
2.2.1 Oncology
2.2.2 Infectious Diseases
2.2.3 Rare Diseases
2.2.4 Autoimmune Diseases
2.2.5 Pulmonary Diseases
2.2.6 Neurological Disorders
2.2.7 Others
2.3 Breakthrough Therapy (BT) Designation Market Size by Type
2.3.1 Breakthrough Therapy (BT) Designation Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Breakthrough Therapy (BT) Designation Market Size Market Share by Type (2017-2022)
2.4 Breakthrough Therapy (BT) Designation Segment by Application
2.4.1 Hospital
2.4.2 Clinic
2.4.3 Research Institute
2.4.4 Laboratories
2.4.5 Others
2.5 Breakthrough Therapy (BT) Designation Market Size by Application
2.5.1 Breakthrough Therapy (BT) Designation Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Breakthrough Therapy (BT) Designation Market Size Market Share by Application (2017-2022)
3 Breakthrough Therapy (BT) Designation Market Size by Player
3.1 Breakthrough Therapy (BT) Designation Market Size Market Share by Players
3.1.1 Global Breakthrough Therapy (BT) Designation Revenue by Players (2020-2022)
3.1.2 Global Breakthrough Therapy (BT) Designation Revenue Market Share by Players (2020-2022)
3.2 Global Breakthrough Therapy (BT) Designation Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Breakthrough Therapy (BT) Designation by Regions
4.1 Breakthrough Therapy (BT) Designation Market Size by Regions (2017-2022)
4.2 Americas Breakthrough Therapy (BT) Designation Market Size Growth (2017-2022)
4.3 APAC Breakthrough Therapy (BT) Designation Market Size Growth (2017-2022)
4.4 Europe Breakthrough Therapy (BT) Designation Market Size Growth (2017-2022)
4.5 Middle East & Africa Breakthrough Therapy (BT) Designation Market Size Growth (2017-2022)
5 Americas
5.1 Americas Breakthrough Therapy (BT) Designation Market Size by Country (2017-2022)
5.2 Americas Breakthrough Therapy (BT) Designation Market Size by Type (2017-2022)
5.3 Americas Breakthrough Therapy (BT) Designation Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Breakthrough Therapy (BT) Designation Market Size by Region (2017-2022)
6.2 APAC Breakthrough Therapy (BT) Designation Market Size by Type (2017-2022)
6.3 APAC Breakthrough Therapy (BT) Designation Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Breakthrough Therapy (BT) Designation by Country (2017-2022)
7.2 Europe Breakthrough Therapy (BT) Designation Market Size by Type (2017-2022)
7.3 Europe Breakthrough Therapy (BT) Designation Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Breakthrough Therapy (BT) Designation by Region (2017-2022)
8.2 Middle East & Africa Breakthrough Therapy (BT) Designation Market Size by Type (2017-2022)
8.3 Middle East & Africa Breakthrough Therapy (BT) Designation Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Breakthrough Therapy (BT) Designation Market Forecast
10.1 Global Breakthrough Therapy (BT) Designation Forecast by Regions (2023-2028)
10.1.1 Global Breakthrough Therapy (BT) Designation Forecast by Regions (2023-2028)
10.1.2 Americas Breakthrough Therapy (BT) Designation Forecast
10.1.3 APAC Breakthrough Therapy (BT) Designation Forecast
10.1.4 Europe Breakthrough Therapy (BT) Designation Forecast
10.1.5 Middle East & Africa Breakthrough Therapy (BT) Designation Forecast
10.2 Americas Breakthrough Therapy (BT) Designation Forecast by Country (2023-2028)
10.2.1 United States Breakthrough Therapy (BT) Designation Market Forecast
10.2.2 Canada Breakthrough Therapy (BT) Designation Market Forecast
10.2.3 Mexico Breakthrough Therapy (BT) Designation Market Forecast
10.2.4 Brazil Breakthrough Therapy (BT) Designation Market Forecast
10.3 APAC Breakthrough Therapy (BT) Designation Forecast by Region (2023-2028)
10.3.1 China Breakthrough Therapy (BT) Designation Market Forecast
10.3.2 Japan Breakthrough Therapy (BT) Designation Market Forecast
10.3.3 Korea Breakthrough Therapy (BT) Designation Market Forecast
10.3.4 Southeast Asia Breakthrough Therapy (BT) Designation Market Forecast
10.3.5 India Breakthrough Therapy (BT) Designation Market Forecast
10.3.6 Australia Breakthrough Therapy (BT) Designation Market Forecast
10.4 Europe Breakthrough Therapy (BT) Designation Forecast by Country (2023-2028)
10.4.1 Germany Breakthrough Therapy (BT) Designation Market Forecast
10.4.2 France Breakthrough Therapy (BT) Designation Market Forecast
10.4.3 UK Breakthrough Therapy (BT) Designation Market Forecast
10.4.4 Italy Breakthrough Therapy (BT) Designation Market Forecast
10.4.5 Russia Breakthrough Therapy (BT) Designation Market Forecast
10.5 Middle East & Africa Breakthrough Therapy (BT) Designation Forecast by Region (2023-2028)
10.5.1 Egypt Breakthrough Therapy (BT) Designation Market Forecast
10.5.2 South Africa Breakthrough Therapy (BT) Designation Market Forecast
10.5.3 Israel Breakthrough Therapy (BT) Designation Market Forecast
10.5.4 Turkey Breakthrough Therapy (BT) Designation Market Forecast
10.5.5 GCC Countries Breakthrough Therapy (BT) Designation Market Forecast
10.6 Global Breakthrough Therapy (BT) Designation Forecast by Type (2023-2028)
10.7 Global Breakthrough Therapy (BT) Designation Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Roche
11.1.1 Roche Company Information
11.1.2 Roche Breakthrough Therapy (BT) Designation Product Offered
11.1.3 Roche Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Roche Main Business Overview
11.1.5 Roche Latest Developments
11.2 Abbvie
11.2.1 Abbvie Company Information
11.2.2 Abbvie Breakthrough Therapy (BT) Designation Product Offered
11.2.3 Abbvie Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Abbvie Main Business Overview
11.2.5 Abbvie Latest Developments
11.3 Novartis International AG
11.3.1 Novartis International AG Company Information
11.3.2 Novartis International AG Breakthrough Therapy (BT) Designation Product Offered
11.3.3 Novartis International AG Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Novartis International AG Main Business Overview
11.3.5 Novartis International AG Latest Developments
11.4 Janssen
11.4.1 Janssen Company Information
11.4.2 Janssen Breakthrough Therapy (BT) Designation Product Offered
11.4.3 Janssen Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Janssen Main Business Overview
11.4.5 Janssen Latest Developments
11.5 BMS
11.5.1 BMS Company Information
11.5.2 BMS Breakthrough Therapy (BT) Designation Product Offered
11.5.3 BMS Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 BMS Main Business Overview
11.5.5 BMS Latest Developments
11.6 Eli Lilly
11.6.1 Eli Lilly Company Information
11.6.2 Eli Lilly Breakthrough Therapy (BT) Designation Product Offered
11.6.3 Eli Lilly Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Eli Lilly Main Business Overview
11.6.5 Eli Lilly Latest Developments
11.7 Gilead
11.7.1 Gilead Company Information
11.7.2 Gilead Breakthrough Therapy (BT) Designation Product Offered
11.7.3 Gilead Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Gilead Main Business Overview
11.7.5 Gilead Latest Developments
11.8 Sanofi
11.8.1 Sanofi Company Information
11.8.2 Sanofi Breakthrough Therapy (BT) Designation Product Offered
11.8.3 Sanofi Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Sanofi Main Business Overview
11.8.5 Sanofi Latest Developments
11.9 Regeneron
11.9.1 Regeneron Company Information
11.9.2 Regeneron Breakthrough Therapy (BT) Designation Product Offered
11.9.3 Regeneron Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Regeneron Main Business Overview
11.9.5 Regeneron Latest Developments
11.10 Acadia
11.10.1 Acadia Company Information
11.10.2 Acadia Breakthrough Therapy (BT) Designation Product Offered
11.10.3 Acadia Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Acadia Main Business Overview
11.10.5 Acadia Latest Developments
11.11 Boehringer Ingelheim
11.11.1 Boehringer Ingelheim Company Information
11.11.2 Boehringer Ingelheim Breakthrough Therapy (BT) Designation Product Offered
11.11.3 Boehringer Ingelheim Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Boehringer Ingelheim Main Business Overview
11.11.5 Boehringer Ingelheim Latest Developments
11.12 Amgen
11.12.1 Amgen Company Information
11.12.2 Amgen Breakthrough Therapy (BT) Designation Product Offered
11.12.3 Amgen Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 Amgen Main Business Overview
11.12.5 Amgen Latest Developments
11.13 AstraZeneca
11.13.1 AstraZeneca Company Information
11.13.2 AstraZeneca Breakthrough Therapy (BT) Designation Product Offered
11.13.3 AstraZeneca Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 AstraZeneca Main Business Overview
11.13.5 AstraZeneca Latest Developments
11.14 GlaxoSmithKline
11.14.1 GlaxoSmithKline Company Information
11.14.2 GlaxoSmithKline Breakthrough Therapy (BT) Designation Product Offered
11.14.3 GlaxoSmithKline Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 GlaxoSmithKline Main Business Overview
11.14.5 GlaxoSmithKline Latest Developments
11.15 Vertex
11.15.1 Vertex Company Information
11.15.2 Vertex Breakthrough Therapy (BT) Designation Product Offered
11.15.3 Vertex Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2020-2022)
11.15.4 Vertex Main Business Overview
11.15.5 Vertex Latest Developments
11.16 Alexion
11.16.1 Alexion Company Information
11.16.2 Alexion Breakthrough Therapy (BT) Designation Product Offered
11.16.3 Alexion Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2020-2022)
11.16.4 Alexion Main Business Overview
11.16.5 Alexion Latest Developments
11.17 Merck
11.17.1 Merck Company Information
11.17.2 Merck Breakthrough Therapy (BT) Designation Product Offered
11.17.3 Merck Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2020-2022)
11.17.4 Merck Main Business Overview
11.17.5 Merck Latest Developments
11.18 Jazz Pharmaceuticals
11.18.1 Jazz Pharmaceuticals Company Information
11.18.2 Jazz Pharmaceuticals Breakthrough Therapy (BT) Designation Product Offered
11.18.3 Jazz Pharmaceuticals Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2020-2022)
11.18.4 Jazz Pharmaceuticals Main Business Overview
11.18.5 Jazz Pharmaceuticals Latest Developments
11.19 Exelixis
11.19.1 Exelixis Company Information
11.19.2 Exelixis Breakthrough Therapy (BT) Designation Product Offered
11.19.3 Exelixis Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2020-2022)
11.19.4 Exelixis Main Business Overview
11.19.5 Exelixis Latest Developments
11.20 Eisai
11.20.1 Eisai Company Information
11.20.2 Eisai Breakthrough Therapy (BT) Designation Product Offered
11.20.3 Eisai Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2020-2022)
11.20.4 Eisai Main Business Overview
11.20.5 Eisai Latest Developments
11.21 Takeda
11.21.1 Takeda Company Information
11.21.2 Takeda Breakthrough Therapy (BT) Designation Product Offered
11.21.3 Takeda Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2020-2022)
11.21.4 Takeda Main Business Overview
11.21.5 Takeda Latest Developments
11.22 Pfizer
11.22.1 Pfizer Company Information
11.22.2 Pfizer Breakthrough Therapy (BT) Designation Product Offered
11.22.3 Pfizer Breakthrough Therapy (BT) Designation Revenue, Gross Margin and Market Share (2020-2022)
11.22.4 Pfizer Main Business Overview
11.22.5 Pfizer Latest Developments
12 Research Findings and Conclusion
Table 1. Breakthrough Therapy (BT) Designation Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Oncology
Table 3. Major Players of Infectious Diseases
Table 4. Major Players of Rare Diseases
Table 5. Major Players of Autoimmune Diseases
Table 6. Major Players of Pulmonary Diseases
Table 7. Major Players of Neurological Disorders
Table 8. Major Players of Others
Table 9. Breakthrough Therapy (BT) Designation Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 10. Global Breakthrough Therapy (BT) Designation Market Size by Type (2017-2022) & ($ Millions)
Table 11. Global Breakthrough Therapy (BT) Designation Market Size Market Share by Type (2017-2022)
Table 12. Breakthrough Therapy (BT) Designation Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 13. Global Breakthrough Therapy (BT) Designation Market Size by Application (2017-2022) & ($ Millions)
Table 14. Global Breakthrough Therapy (BT) Designation Market Size Market Share by Application (2017-2022)
Table 15. Global Breakthrough Therapy (BT) Designation Revenue by Players (2020-2022) & ($ Millions)
Table 16. Global Breakthrough Therapy (BT) Designation Revenue Market Share by Player (2020-2022)
Table 17. Breakthrough Therapy (BT) Designation Key Players Head office and Products Offered
Table 18. Breakthrough Therapy (BT) Designation Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 19. New Products and Potential Entrants
Table 20. Mergers & Acquisitions, Expansion
Table 21. Global Breakthrough Therapy (BT) Designation Market Size by Regions 2017-2022 & ($ Millions)
Table 22. Global Breakthrough Therapy (BT) Designation Market Size Market Share by Regions (2017-2022)
Table 23. Americas Breakthrough Therapy (BT) Designation Market Size by Country (2017-2022) & ($ Millions)
Table 24. Americas Breakthrough Therapy (BT) Designation Market Size Market Share by Country (2017-2022)
Table 25. Americas Breakthrough Therapy (BT) Designation Market Size by Type (2017-2022) & ($ Millions)
Table 26. Americas Breakthrough Therapy (BT) Designation Market Size Market Share by Type (2017-2022)
Table 27. Americas Breakthrough Therapy (BT) Designation Market Size by Application (2017-2022) & ($ Millions)
Table 28. Americas Breakthrough Therapy (BT) Designation Market Size Market Share by Application (2017-2022)
Table 29. APAC Breakthrough Therapy (BT) Designation Market Size by Region (2017-2022) & ($ Millions)
Table 30. APAC Breakthrough Therapy (BT) Designation Market Size Market Share by Region (2017-2022)
Table 31. APAC Breakthrough Therapy (BT) Designation Market Size by Type (2017-2022) & ($ Millions)
Table 32. APAC Breakthrough Therapy (BT) Designation Market Size Market Share by Type (2017-2022)
Table 33. APAC Breakthrough Therapy (BT) Designation Market Size by Application (2017-2022) & ($ Millions)
Table 34. APAC Breakthrough Therapy (BT) Designation Market Size Market Share by Application (2017-2022)
Table 35. Europe Breakthrough Therapy (BT) Designation Market Size by Country (2017-2022) & ($ Millions)
Table 36. Europe Breakthrough Therapy (BT) Designation Market Size Market Share by Country (2017-2022)
Table 37. Europe Breakthrough Therapy (BT) Designation Market Size by Type (2017-2022) & ($ Millions)
Table 38. Europe Breakthrough Therapy (BT) Designation Market Size Market Share by Type (2017-2022)
Table 39. Europe Breakthrough Therapy (BT) Designation Market Size by Application (2017-2022) & ($ Millions)
Table 40. Europe Breakthrough Therapy (BT) Designation Market Size Market Share by Application (2017-2022)
Table 41. Middle East & Africa Breakthrough Therapy (BT) Designation Market Size by Region (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Breakthrough Therapy (BT) Designation Market Size Market Share by Region (2017-2022)
Table 43. Middle East & Africa Breakthrough Therapy (BT) Designation Market Size by Type (2017-2022) & ($ Millions)
Table 44. Middle East & Africa Breakthrough Therapy (BT) Designation Market Size Market Share by Type (2017-2022)
Table 45. Middle East & Africa Breakthrough Therapy (BT) Designation Market Size by Application (2017-2022) & ($ Millions)
Table 46. Middle East & Africa Breakthrough Therapy (BT) Designation Market Size Market Share by Application (2017-2022)
Table 47. Key Market Drivers & Growth Opportunities of Breakthrough Therapy (BT) Designation
Table 48. Key Market Challenges & Risks of Breakthrough Therapy (BT) Designation
Table 49. Key Industry Trends of Breakthrough Therapy (BT) Designation
Table 50. Global Breakthrough Therapy (BT) Designation Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 51. Global Breakthrough Therapy (BT) Designation Market Size Market Share Forecast by Regions (2023-2028)
Table 52. Global Breakthrough Therapy (BT) Designation Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 53. Global Breakthrough Therapy (BT) Designation Market Size Market Share Forecast by Type (2023-2028)
Table 54. Global Breakthrough Therapy (BT) Designation Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 55. Global Breakthrough Therapy (BT) Designation Market Size Market Share Forecast by Application (2023-2028)
Table 56. Roche Details, Company Type, Breakthrough Therapy (BT) Designation Area Served and Its Competitors
Table 57. Roche Breakthrough Therapy (BT) Designation Product Offered
Table 58. Roche Breakthrough Therapy (BT) Designation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 59. Roche Main Business
Table 60. Roche Latest Developments
Table 61. Abbvie Details, Company Type, Breakthrough Therapy (BT) Designation Area Served and Its Competitors
Table 62. Abbvie Breakthrough Therapy (BT) Designation Product Offered
Table 63. Abbvie Main Business
Table 64. Abbvie Breakthrough Therapy (BT) Designation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Abbvie Latest Developments
Table 66. Novartis International AG Details, Company Type, Breakthrough Therapy (BT) Designation Area Served and Its Competitors
Table 67. Novartis International AG Breakthrough Therapy (BT) Designation Product Offered
Table 68. Novartis International AG Main Business
Table 69. Novartis International AG Breakthrough Therapy (BT) Designation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Novartis International AG Latest Developments
Table 71. Janssen Details, Company Type, Breakthrough Therapy (BT) Designation Area Served and Its Competitors
Table 72. Janssen Breakthrough Therapy (BT) Designation Product Offered
Table 73. Janssen Main Business
Table 74. Janssen Breakthrough Therapy (BT) Designation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Janssen Latest Developments
Table 76. BMS Details, Company Type, Breakthrough Therapy (BT) Designation Area Served and Its Competitors
Table 77. BMS Breakthrough Therapy (BT) Designation Product Offered
Table 78. BMS Main Business
Table 79. BMS Breakthrough Therapy (BT) Designation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. BMS Latest Developments
Table 81. Eli Lilly Details, Company Type, Breakthrough Therapy (BT) Designation Area Served and Its Competitors
Table 82. Eli Lilly Breakthrough Therapy (BT) Designation Product Offered
Table 83. Eli Lilly Main Business
Table 84. Eli Lilly Breakthrough Therapy (BT) Designation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Eli Lilly Latest Developments
Table 86. Gilead Details, Company Type, Breakthrough Therapy (BT) Designation Area Served and Its Competitors
Table 87. Gilead Breakthrough Therapy (BT) Designation Product Offered
Table 88. Gilead Main Business
Table 89. Gilead Breakthrough Therapy (BT) Designation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Gilead Latest Developments
Table 91. Sanofi Details, Company Type, Breakthrough Therapy (BT) Designation Area Served and Its Competitors
Table 92. Sanofi Breakthrough Therapy (BT) Designation Product Offered
Table 93. Sanofi Main Business
Table 94. Sanofi Breakthrough Therapy (BT) Designation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Sanofi Latest Developments
Table 96. Regeneron Details, Company Type, Breakthrough Therapy (BT) Designation Area Served and Its Competitors
Table 97. Regeneron Breakthrough Therapy (BT) Designation Product Offered
Table 98. Regeneron Main Business
Table 99. Regeneron Breakthrough Therapy (BT) Designation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Regeneron Latest Developments
Table 101. Acadia Details, Company Type, Breakthrough Therapy (BT) Designation Area Served and Its Competitors
Table 102. Acadia Breakthrough Therapy (BT) Designation Product Offered
Table 103. Acadia Main Business
Table 104. Acadia Breakthrough Therapy (BT) Designation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. Acadia Latest Developments
Table 106. Boehringer Ingelheim Details, Company Type, Breakthrough Therapy (BT) Designation Area Served and Its Competitors
Table 107. Boehringer Ingelheim Breakthrough Therapy (BT) Designation Product Offered
Table 108. Boehringer Ingelheim Breakthrough Therapy (BT) Designation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 109. Boehringer Ingelheim Main Business
Table 110. Boehringer Ingelheim Latest Developments
Table 111. Amgen Details, Company Type, Breakthrough Therapy (BT) Designation Area Served and Its Competitors
Table 112. Amgen Breakthrough Therapy (BT) Designation Product Offered
Table 113. Amgen Main Business
Table 114. Amgen Breakthrough Therapy (BT) Designation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 115. Amgen Latest Developments
Table 116. AstraZeneca Details, Company Type, Breakthrough Therapy (BT) Designation Area Served and Its Competitors
Table 117. AstraZeneca Breakthrough Therapy (BT) Designation Product Offered
Table 118. AstraZeneca Main Business
Table 119. AstraZeneca Breakthrough Therapy (BT) Designation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 120. AstraZeneca Latest Developments
Table 121. GlaxoSmithKline Details, Company Type, Breakthrough Therapy (BT) Designation Area Served and Its Competitors
Table 122. GlaxoSmithKline Breakthrough Therapy (BT) Designation Product Offered
Table 123. GlaxoSmithKline Main Business
Table 124. GlaxoSmithKline Breakthrough Therapy (BT) Designation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 125. GlaxoSmithKline Latest Developments
Table 126. Vertex Details, Company Type, Breakthrough Therapy (BT) Designation Area Served and Its Competitors
Table 127. Vertex Breakthrough Therapy (BT) Designation Product Offered
Table 128. Vertex Main Business
Table 129. Vertex Breakthrough Therapy (BT) Designation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 130. Vertex Latest Developments
Table 131. Alexion Details, Company Type, Breakthrough Therapy (BT) Designation Area Served and Its Competitors
Table 132. Alexion Breakthrough Therapy (BT) Designation Product Offered
Table 133. Alexion Main Business
Table 134. Alexion Breakthrough Therapy (BT) Designation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 135. Alexion Latest Developments
Table 136. Merck Details, Company Type, Breakthrough Therapy (BT) Designation Area Served and Its Competitors
Table 137. Merck Breakthrough Therapy (BT) Designation Product Offered
Table 138. Merck Main Business
Table 139. Merck Breakthrough Therapy (BT) Designation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 140. Merck Latest Developments
Table 141. Jazz Pharmaceuticals Details, Company Type, Breakthrough Therapy (BT) Designation Area Served and Its Competitors
Table 142. Jazz Pharmaceuticals Breakthrough Therapy (BT) Designation Product Offered
Table 143. Jazz Pharmaceuticals Main Business
Table 144. Jazz Pharmaceuticals Breakthrough Therapy (BT) Designation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 145. Jazz Pharmaceuticals Latest Developments
Table 146. Exelixis Details, Company Type, Breakthrough Therapy (BT) Designation Area Served and Its Competitors
Table 147. Exelixis Breakthrough Therapy (BT) Designation Product Offered
Table 148. Exelixis Main Business
Table 149. Exelixis Breakthrough Therapy (BT) Designation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 150. Exelixis Latest Developments
Table 151. Eisai Details, Company Type, Breakthrough Therapy (BT) Designation Area Served and Its Competitors
Table 152. Eisai Breakthrough Therapy (BT) Designation Product Offered
Table 153. Eisai Main Business
Table 154. Eisai Breakthrough Therapy (BT) Designation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 155. Eisai Latest Developments
Table 156. Takeda Details, Company Type, Breakthrough Therapy (BT) Designation Area Served and Its Competitors
Table 157. Takeda Breakthrough Therapy (BT) Designation Product Offered
Table 158. Takeda Breakthrough Therapy (BT) Designation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 159. Takeda Main Business
Table 160. Takeda Latest Developments
Table 161. Pfizer Details, Company Type, Breakthrough Therapy (BT) Designation Area Served and Its Competitors
Table 162. Pfizer Breakthrough Therapy (BT) Designation Product Offered
Table 163. Pfizer Main Business
Table 164. Pfizer Breakthrough Therapy (BT) Designation Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 165. Pfizer Latest Developments
List of Figures
Figure 1. Breakthrough Therapy (BT) Designation Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Breakthrough Therapy (BT) Designation Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Breakthrough Therapy (BT) Designation Market Size Market Share by Type in 2021
Figure 7. Breakthrough Therapy (BT) Designation in Hospital
Figure 8. Global Breakthrough Therapy (BT) Designation Market: Hospital (2017-2022) & ($ Millions)
Figure 9. Breakthrough Therapy (BT) Designation in Clinic
Figure 10. Global Breakthrough Therapy (BT) Designation Market: Clinic (2017-2022) & ($ Millions)
Figure 11. Breakthrough Therapy (BT) Designation in Research Institute
Figure 12. Global Breakthrough Therapy (BT) Designation Market: Research Institute (2017-2022) & ($ Millions)
Figure 13. Breakthrough Therapy (BT) Designation in Laboratories
Figure 14. Global Breakthrough Therapy (BT) Designation Market: Laboratories (2017-2022) & ($ Millions)
Figure 15. Breakthrough Therapy (BT) Designation in Others
Figure 16. Global Breakthrough Therapy (BT) Designation Market: Others (2017-2022) & ($ Millions)
Figure 17. Global Breakthrough Therapy (BT) Designation Market Size Market Share by Application in 2021
Figure 18. Global Breakthrough Therapy (BT) Designation Revenue Market Share by Player in 2021
Figure 19. Global Breakthrough Therapy (BT) Designation Market Size Market Share by Regions (2017-2022)
Figure 20. Americas Breakthrough Therapy (BT) Designation Market Size 2017-2022 ($ Millions)
Figure 21. APAC Breakthrough Therapy (BT) Designation Market Size 2017-2022 ($ Millions)
Figure 22. Europe Breakthrough Therapy (BT) Designation Market Size 2017-2022 ($ Millions)
Figure 23. Middle East & Africa Breakthrough Therapy (BT) Designation Market Size 2017-2022 ($ Millions)
Figure 24. Americas Breakthrough Therapy (BT) Designation Value Market Share by Country in 2021
Figure 25. Americas Breakthrough Therapy (BT) Designation Consumption Market Share by Type in 2021
Figure 26. Americas Breakthrough Therapy (BT) Designation Market Size Market Share by Application in 2021
Figure 27. United States Breakthrough Therapy (BT) Designation Market Size Growth 2017-2022 ($ Millions)
Figure 28. Canada Breakthrough Therapy (BT) Designation Market Size Growth 2017-2022 ($ Millions)
Figure 29. Mexico Breakthrough Therapy (BT) Designation Market Size Growth 2017-2022 ($ Millions)
Figure 30. Brazil Breakthrough Therapy (BT) Designation Market Size Growth 2017-2022 ($ Millions)
Figure 31. APAC Breakthrough Therapy (BT) Designation Market Size Market Share by Region in 2021
Figure 32. APAC Breakthrough Therapy (BT) Designation Market Size Market Share by Application in 2021
Figure 33. China Breakthrough Therapy (BT) Designation Market Size Growth 2017-2022 ($ Millions)
Figure 34. Japan Breakthrough Therapy (BT) Designation Market Size Growth 2017-2022 ($ Millions)
Figure 35. Korea Breakthrough Therapy (BT) Designation Market Size Growth 2017-2022 ($ Millions)
Figure 36. Southeast Asia Breakthrough Therapy (BT) Designation Market Size Growth 2017-2022 ($ Millions)
Figure 37. India Breakthrough Therapy (BT) Designation Market Size Growth 2017-2022 ($ Millions)
Figure 38. Australia Breakthrough Therapy (BT) Designation Market Size Growth 2017-2022 ($ Millions)
Figure 39. Europe Breakthrough Therapy (BT) Designation Market Size Market Share by Country in 2021
Figure 40. Europe Breakthrough Therapy (BT) Designation Market Size Market Share by Type in 2021
Figure 41. Europe Breakthrough Therapy (BT) Designation Market Size Market Share by Application in 2021
Figure 42. Germany Breakthrough Therapy (BT) Designation Market Size Growth 2017-2022 ($ Millions)
Figure 43. France Breakthrough Therapy (BT) Designation Market Size Growth 2017-2022 ($ Millions)
Figure 44. UK Breakthrough Therapy (BT) Designation Market Size Growth 2017-2022 ($ Millions)
Figure 45. Italy Breakthrough Therapy (BT) Designation Market Size Growth 2017-2022 ($ Millions)
Figure 46. Russia Breakthrough Therapy (BT) Designation Market Size Growth 2017-2022 ($ Millions)
Figure 47. Middle East & Africa Breakthrough Therapy (BT) Designation Market Size Market Share by Region in 2021
Figure 48. Middle East & Africa Breakthrough Therapy (BT) Designation Market Size Market Share by Type in 2021
Figure 49. Middle East & Africa Breakthrough Therapy (BT) Designation Market Size Market Share by Application in 2021
Figure 50. Egypt Breakthrough Therapy (BT) Designation Market Size Growth 2017-2022 ($ Millions)
Figure 51. South Africa Breakthrough Therapy (BT) Designation Market Size Growth 2017-2022 ($ Millions)
Figure 52. Israel Breakthrough Therapy (BT) Designation Market Size Growth 2017-2022 ($ Millions)
Figure 53. Turkey Breakthrough Therapy (BT) Designation Market Size Growth 2017-2022 ($ Millions)
Figure 54. GCC Country Breakthrough Therapy (BT) Designation Market Size Growth 2017-2022 ($ Millions)
Figure 55. Americas Breakthrough Therapy (BT) Designation Market Size 2023-2028 ($ Millions)
Figure 56. APAC Breakthrough Therapy (BT) Designation Market Size 2023-2028 ($ Millions)
Figure 57. Europe Breakthrough Therapy (BT) Designation Market Size 2023-2028 ($ Millions)
Figure 58. Middle East & Africa Breakthrough Therapy (BT) Designation Market Size 2023-2028 ($ Millions)
Figure 59. United States Breakthrough Therapy (BT) Designation Market Size 2023-2028 ($ Millions)
Figure 60. Canada Breakthrough Therapy (BT) Designation Market Size 2023-2028 ($ Millions)
Figure 61. Mexico Breakthrough Therapy (BT) Designation Market Size 2023-2028 ($ Millions)
Figure 62. Brazil Breakthrough Therapy (BT) Designation Market Size 2023-2028 ($ Millions)
Figure 63. China Breakthrough Therapy (BT) Designation Market Size 2023-2028 ($ Millions)
Figure 64. Japan Breakthrough Therapy (BT) Designation Market Size 2023-2028 ($ Millions)
Figure 65. Korea Breakthrough Therapy (BT) Designation Market Size 2023-2028 ($ Millions)
Figure 66. Southeast Asia Breakthrough Therapy (BT) Designation Market Size 2023-2028 ($ Millions)
Figure 67. India Breakthrough Therapy (BT) Designation Market Size 2023-2028 ($ Millions)
Figure 68. Australia Breakthrough Therapy (BT) Designation Market Size 2023-2028 ($ Millions)
Figure 69. Germany Breakthrough Therapy (BT) Designation Market Size 2023-2028 ($ Millions)
Figure 70. France Breakthrough Therapy (BT) Designation Market Size 2023-2028 ($ Millions)
Figure 71. UK Breakthrough Therapy (BT) Designation Market Size 2023-2028 ($ Millions)
Figure 72. Italy Breakthrough Therapy (BT) Designation Market Size 2023-2028 ($ Millions)
Figure 73. Russia Breakthrough Therapy (BT) Designation Market Size 2023-2028 ($ Millions)
Figure 74. Spain Breakthrough Therapy (BT) Designation Market Size 2023-2028 ($ Millions)
Figure 75. Egypt Breakthrough Therapy (BT) Designation Market Size 2023-2028 ($ Millions)
Figure 76. South Africa Breakthrough Therapy (BT) Designation Market Size 2023-2028 ($ Millions)
Figure 77. Israel Breakthrough Therapy (BT) Designation Market Size 2023-2028 ($ Millions)
Figure 78. Turkey Breakthrough Therapy (BT) Designation Market Size 2023-2028 ($ Millions)
Figure 79. GCC Countries Breakthrough Therapy (BT) Designation Market Size 2023-2028 ($ Millions)
Similar Reports
This report provides an overview of the French molecular diagnostic testing market, including test volume, and sales forecasts by Application, 2019-2023, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
This report provides an overview of the German molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
This report provides an overview of the Italian molecular diagnostic testing market, including test volume, and sales forecasts by application, and supplier shares by test.
Table of Contents
Business Environment
Market Structure
Market Size, Growth, and Major Suppliers' Market Shares
&nb...
- Publish Date: April 1, 2019
- $450
